Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 7.82%
- NET SALES(Latest six months) At Rs 5.94 cr has Grown at -48.12%
- PAT(Latest six months) At Rs -0.48 cr has Grown at -48.12%
With ROE of 1, it has a Very Expensive valuation with a 0.8 Price to Book Value
Stock DNA
Trading & Distributors
INR 57 Cr (Micro Cap)
74.00
24
0.00%
0.00
1.02%
0.72
Total Returns (Price + Dividend) 
Dhanlaxmi Cotex for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Dhanlaxmi Cotex Sees Revision in Market Evaluation Amid Challenging Fundamentals
Dhanlaxmi Cotex, a microcap player in the Trading & Distributors sector, has undergone a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. The recent assessment highlights a more cautious stance driven by multiple factors including operational performance, valuation concerns, and market trends.
Read More
Dhanlaxmi Cotex Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
Dhanlaxmi Cotex Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market behaviour signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility and underperformance relative to the broader market.
Read More
Dhanlaxmi Cotex Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit
Dhanlaxmi Cotex Ltd has captured market attention with extraordinary buying momentum, registering a rare scenario where only buy orders populate the queue, pushing the stock into an upper circuit. This exceptional demand, coupled with a four-day consecutive gain, signals a potential multi-day circuit phenomenon that investors are closely monitoring.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Change in Management
18-Dec-2025 | Source : BSEIn terms of Regulation 30 of SEBI (LODR) Regulations 2015 as amended this is to inform that the Board of Directors held in its meeting today on 18.12.2025 has appointed Mrs. Payal Ankur Bankda (DIN: 09483787) as the Chief Financial Officer of the Company w.e.f. 18.12.2025. Attached is the brief profile of Mrs. Payal Ankur Bankda in term of Circular CIR/CFD/CMD/4/2015 dated September 9 2015 readwith SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 112023
Board Meeting Outcome for Outcome Of Board Meeting Held On 18.12.2025
18-Dec-2025 | Source : BSEIn terms of Regulations 30 SEBI (LODR) Regulations 2015 this is to inform that the Meeting of the Board of Directors of the Company was held today on 18th December 2025 Thursday at the registered office of the Company at 3:00 p.m. and concluded at around 04.00 p.m. The Board inter-alia considered and approved the following matters. 1. Appointment of Mrs. Payal Ankur Bankda as a Chief Financial Officer of the Company w.e.f. 18th December 2025. 2. Take on record resignation of Mr. Rahul Mahesh Jhawar (DIN: 07590581) from the post of Executive Director & Chief Financial Officer of the Company w.e.f. 9th December 2025. Kindly acknowledge the Receipt.
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (LODR) Regulations 2015 For Board Meeting Scheduled On 18.12.2025 At 03.00 P.M. At Its Registered Office.
10-Dec-2025 | Source : BSEDhanlaxmi Cotex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/12/2025 inter alia to consider and approve 1. The appointment of Mrs. Payal Ankur Bankda as a Chief Financial Officer (CFO) of the Company. 2. Any other items with the permission of Chairman.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Mahesh Sohanlal Jhawar (67.0%)
Eskay Niryat Pvt Ltd (10.87%)
14.05%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 175.95% vs 81.61% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 136.00% vs 64.11% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -46.96% vs -41.08% in Sep 2024
Growth in half year ended Sep 2025 is -109.40% vs 128.31% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -40.41% vs 17.28% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 169.45% vs 418.33% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -46.19% vs 11.29% in Mar 2024
YoY Growth in year ended Mar 2025 is 100.35% vs 1,104.17% in Mar 2024






